Literature DB >> 32474910

Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period.

Vincenzo Zanardo1, Valeria Manghina1, Lara Giliberti1, Michela Vettore1, Lorenzo Severino1, Gianluca Straface1.   

Abstract

OBJECTIVE: To explore whether quarantine measures and hospital containment policies among women giving birth in a COVID-19 "hotspot" area in northeastern Italy enhanced psycho-emotional distress in the immediate postpartum period.
METHODS: We designed a non-concurrent case-control study of mothers who gave birth during a COVID-19 quarantine period between March 8 and May 3, 2020 (COVID-19 study group), with an antecedent group of matched postpartum women (control group) who delivered in the same period in 2019. Participants completed the Edinburgh Postnatal Depression Scale (EPDS) on the second day postpartum.
RESULTS: The COVID-19 study group (n=91) had significantly higher mean EPDS scores compared with the control group (n=101) (8.5 ± 4.6 vs 6.34 ± 4.1; P<0.001). Furthermore, 28.6% of women in the COVID-19 group had a global EPDS score above 12. Analysis of three EPDS subscales revealed significantly higher scores among the COVID-19 group compared with the control group for anhedonia (0.60 ± 0.61 vs 0.19 ± 0.36; P<0.001) and depression (0.58 ± 0.54 vs 0.35 ± 0.45; P=0.001).
CONCLUSIONS: Concerns about risk of exposure to COVID-19, combined with quarantine measures adopted during the COVID-19 pandemic, adversely affected the thoughts and emotions of new mothers, worsening depressive symptoms.
© 2020 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Anhedonia; Anxiety; COVID-19; Coronavirus; Depression; Edinburgh Postnatal Depression Scale; Postpartum period; Quarantine

Mesh:

Year:  2020        PMID: 32474910      PMCID: PMC9087548          DOI: 10.1002/ijgo.13249

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   4.447


INTRODUCTION

In February 2020, northern Italy became the epicenter for coronavirus disease 2019 (COVID‐19) in Europe, with many exportations to other countries and widespread community transmission, particularly within the region. As a public health response, on February 22, 2020, Italy imposed a lockdown for 14 days comprising shutdown of businesses, schools, and public places, as well as physical distancing in “hotspot” towns close to Milan and Venice. On March 8, quarantine measures were expanded to all of Lombardy and 14 other northern provinces. By March 9, 7375 laboratory‐confirmed cases of COVID‐19 and 366 deaths had been observed in Italy. Hence, on that date, quarantine was extended nationwide until April 13 to limit viral transmission. , Following the Decree of The Council of Ministers on April 10, 2020, all measures to counter the spread of coronavirus infection were extended until May 3. After this date, phase two began, with eased lockdown measures implemented to “coexist” with the coronavirus. The municipality of Vo’ in the Veneto region of northeastern Italy (about 45 km from Venice) was identified as a COVID‐19 hotspot. On February 21, the death of one of its residents, a 78‐year‐old man, was registered. He became the first known Italian—and European—to die of COVID‐19. Most of the COVID‐19 victims from this area were elderly. Pregnant women are a minority group, with low and late fertility and high sociocultural status. On average, around 1000 neonates are born annually at the Policlinico Abano Terme, a suburban hospital located about 15 km southwest of Vo’. The hospital borders the municipalities most devastated by the COVID‐19 epidemic. Several studies have documented maternal psycho‐emotional vulnerability during catastrophic events. Trauma, terrorist attack, and natural and man‐made disasters (e.g. earthquakes, tsunamis, and Chernobyl) were predictors of postpartum depression symptoms for mothers in the general population. , , After the outbreak of severe acute respiratory syndrome (SARS) in 2003, both healthcare workers and people who were self‐quarantined exhibited symptoms of post‐traumatic stress disorder. Hence, the effect of stress caused by COVID‐19 on pregnant women cannot be ignored. Pregnant women are considered an at‐risk population for viral respiratory infections with possible consequences for the mother and fetus; however, at present, little information exists on the susceptibility of pregnant women to the pathology of COVID‐19. Since the beginning of the COVID‐19 epidemic in Italy, the Italian central and regional government implemented primary prevention actions and tailored several restrictive measures to contain the spread of the infection. These measures included isolation of cases, contact tracing, and quarantine and mitigation measures, including general lockdown and social or personal distancing—lessons learned from China’s successful battle against COVID‐19. Hospitals changed policies around prenatal care, labor and delivery, and postnatal care, replacing office visits with remote checkups, sending pregnant women to an offsite laboratory for blood tests, cancelling birth center tours and other nonessential visits, and barring extra people (fathers, doulas, and visitors) from the delivery room and postpartum units in an effort to keep mothers and babies safe. People in quarantine may experience a wide range of feelings, including fear, anger, sadness, irritability, guilt, or confusion, which may make isolation challenging for maternal health. , The aim of the present study was to explore whether quarantine measures and hospital containment policies among women giving birth in a hotspot area for COVID‐19 enhanced psycho‐emotional distress in the immediate postpartum period. We tested for anhedonia, anxiety, and depression using the Edinburgh Postnatal Depression Scale (EPDS) in the immediate postpartum period. , Understanding the relationship between stress and maternal health is critical for the development of a complete support system in the setting of an extremely contagious pandemic.

MATERIALS AND METHODS

The study was designed as a non‐concurrent case–control study on psycho‐emotional distress in the immediate postpartum period in women who gave birth at Policlinico Abano Terme (COVID‐19 study group) and an antecedent group of matched postpartum women (control group). Data collection was approved by the Institutional Review Board (IRB) of Policlinico Abano Terme. Ethical approval was also obtained from the IRB. All participants were given an information sheet and were only included in the study if they had signed the consent form. Women aged over 18 years who could read and understand Italian, who had delivered a singleton, healthy neonate at term at Policlinico Abano Terme between March 8 (start of nationwide quarantine) and May 3 (quarantine measures eased), 2020 were consecutively asked to participate. A control group of women was also recruited, comprising women aged over 18 years (able to read and understand Italian) who lived in the same geographic area and had delivered at the hospital in the same time period as the study group but in the previous year (2019). This was possible because mothers provided written permission for us to access their obstetric records, which included basic personal data, education, medical history, and pre‐discharge EPDS screening results. The EPDS is a self‐administered questionnaire made up of 10 items scored using a four‐point Likert scale (0–3) designed to screen for symptoms of postpartum depression. Postpartum depression represents the end of a continuum of severity of symptoms. The present study used a cutoff point for depressive symptomatology risk of higher than 12. Several authors have studied the structure of the EPDS and found that, along with postpartum depressive symptomatology risk, it also measures anxiety and anhedonia. Tuohy and McVey extracted three subscales from the EPDS: anhedonia subscale (items 1 and 2); anxiety subscale (items 3–6); and depression subscale (items 7–10). According to standard maternity routines, in the absence of obstetric or neonatal complications, length of hospital stay was scheduled at 48 hours for both vaginal and cesarean delivery. During the study period (March 8 to May 3), the EPDS was distributed prior to discharge to 113 women (COVID‐19 study group) on the second day postpartum. During the corresponding period in 2019, the EPDS had been distributed to 106 women (control group). A total of 11 women were excluded from the study group: 5 whose length of hospital stay was prolonged; 2 who underwent general anesthesia; 1 who underwent psychological treatment; 1 who required hospitalization for COVID‐19; and 2 whose infants had jaundice. Four women were excluded from the control group: 3 whose length of hospital stay was prolonged and 1 whose infant had jaundice. Among eligible mothers, seven subsequently declined to participate (6 in the study group and 1 in the control group). In addition, five women in the study group were excluded owing to incomplete data. Thus, data from 91 women in the study group and 101 in the control group were analyzed. SPSS version 19 (IBM, Armonk, NY, USA) was used for analysis. Data are expressed as mean ± SD or number (percentage). EPDS global score and values for the three subscales of anhedonia, anxiety, and depression were determined for the study and control groups. Continuous variables were analyzed by independent sample t test, while the Fisher exact test was used to analyze qualitative variables. P<0.05 was considered statistically significant.

RESULTS

The sociodemographic characteristics and clinical features of 91 study group mothers and 101 control group mothers are shown in Table 1. There were no significant differences between the groups for all variables except neonatal birth weight, which was significantly lower in the babies born during the COVID‐19 pandemic compared with the previous year (3354.51 ± 374.2 vs 3478.60 ± 409.8 g; P=0.031).
Table 1

Sociodemographic characteristics and clinical features of mothers who gave birth between March 8 and May 3, 2020 (COVID‐19 study group) and mothers who gave birth during the same period in the previous year (control group).

CharacteristicsCOVID‐19 study groupControl group P value
n=19291 (47.4)101 (52.6)
Age, y33.73 ± 5.0132.98 ± 5.070.301
Gestational age, wk39.41 ± 1.1239.42 ± 1.140.966
Parity
Nulliparous49 (53.8)52 (51.5)0.774
Level of education
Elementary9 (9.9)7 (6.9)0.603
High59 (64.8)62 (61.4)0.655
Degree27 (29.7)32 (31.7)0.876
Civil status
Single0 (0)0 (0)1.000
Married52 (57.1)61 (60.4)0.662
Cohabitating39 (42.9)40 (39.6)0.622
Occupation
Student1 (1.1)1 (1.5)1.000
Housewife8 (8.8)9 (11.1)1.000
Unemployed8 (8.8)5 (5.0)0.391
Working74 (81.3)86 (85.1)0.562
Gestational BMI >3018.0 (19.8)17.0 (16.8)0.709
Cesarean delivery12 (13.2)12 (11.9)0.830
Elective9 (9.9)8 (7.9)0.800
Emergency3 (3.3)4 (4.4)1.000
Neonatal birth weight, g3354.51 ± 374.23478.60 ± 409.80.031

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared).

Values are given as mean ± SD or number (%).

Sociodemographic characteristics and clinical features of mothers who gave birth between March 8 and May 3, 2020 (COVID‐19 study group) and mothers who gave birth during the same period in the previous year (control group). Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared). Values are given as mean ± SD or number (%). Pre‐discharge EPDS, anhedonia, anxiety, and depression subscale scores collected on the second day postpartum for the COVID‐19 study group and control group are shown in Table 2. Mean EPDS scores were significantly higher in the COVID‐19 study group compared with the control group (8.5 ± 4.6 vs 6.34 ± 4.1; P<0.001). The percentage of high‐risk women, those with a global EPDS score above 12, was also significantly higher in the COVID‐19 group compared with the control group (28.6% vs 11.9%; P=0.006).
Table 2

Edinburgh Postnatal Depression Scale, anhedonia, anxiety, and depression subscale scores of mothers who gave birth between March 8 and May 3, 2020 (COVID‐19 study group) and mothers who gave birth during the same period in the previous year (control group).

ScaleCOVID‐19 study groupControl group P value
n=19291 (47.4)101 (52.6)
EPDS total score8.5 ± 4.66.34 ± 4.1<0.001
EPDS subscale analysis
Anhedonia0.60 ± 0.610.19 ± 0.36<0.001
Anxiety1.28 ± 0.611.14 ± 0.730.141
Depression0.58 ± 0.540.35 ± 0.450.001
EPDS global score >1226 (28.6)12 (11.9)0.006

Abbreviation: EPDS, Edinburgh Postnatal Depression Scale.

Values are given as mean ± SD or number (%).

Edinburgh Postnatal Depression Scale, anhedonia, anxiety, and depression subscale scores of mothers who gave birth between March 8 and May 3, 2020 (COVID‐19 study group) and mothers who gave birth during the same period in the previous year (control group). Abbreviation: EPDS, Edinburgh Postnatal Depression Scale. Values are given as mean ± SD or number (%). EPDS subscale analysis showed that mean scores for anhedonia, anxiety, and depression were all higher in the COVID‐19 study group compared with the control group, although the differences were only significant for anhedonia (0.60 ± 0.61 vs 0.19 ± 0.36; P<0.001) and depression (0.58 ± 0.54 vs 0.35 ± 0.45; P=0.001).

DISCUSSION

The present study found that women giving birth during a period of COVID‐19 quarantine measures adopted in a hotspot area in northeastern Italy between March 8 and May 3, 2020, presented higher EPDS scores compared with a control group of mothers who gave birth during the same period the previous year. Furthermore, almost 30% of mothers in the COVID‐19 group had a global EPDS score above 12, which may lead to a higher risk of postnatal depression. Analysis of three EPDS subscales revealed significantly higher scores for anhedonia and depression in the COVID‐19 study group, highlighting the additional beneficial tools within the EPDS that may allow better understanding of the spectrum of various negative psychological issues that the COVID‐19 pandemic might arouse among pregnant women and new mothers. The present findings suggest that postpartum psychological responses during the COVID‐19 pandemic may be mediated by EPDS symptoms that are severe enough to predict a higher risk of postnatal depression. Therefore, pregnant women giving birth during the COVID‐19 pandemic represent a high‐risk, vulnerable population that needs to be carefully followed to minimize postpartum mental dysfunction, as previous studies have reported following natural disasters. Medical and mental healthcare interventions should be carried out immediately to prevent deterioration of maternal psychological health, which is made more severe by social containment than reported for previous natural disasters. These data may have some clinical relevance. Pregnancy can be a stressful time for many expectant mothers ; however, the COVID‐19 crisis is adding a new layer of worry about how the pandemic will impact the birth of their baby. Research has shown fairly consistent evidence that exposure to a variety of stressors during pregnancy is associated with increased risk of postpartum depression symptoms and emotional problems. Women in the COVID‐19 group reported various negative psychological emotions, such as anhedonia and depression, and had a higher risk of postpartum depression shown by EPDS scores above 12 in one in three mothers. Postpartum depression is the result of a dynamic interplay between biological, psychological, and social risk factors, all of which may be amplified during the current COVID‐19 pandemic. To our knowledge, this is the first study to assess EPDS scores in a sample of women giving birth in an area severely affected by COVID‐19. WHO declared that “Containment of COVID‐19 is feasible and must remain the top priority for all countries”. Nevertheless, concerns about exposure to COVID‐19, combined with physical distancing and containment recommendations, may adversely affect the thoughts, emotions, and functioning of new mothers, thereby worsening depressive symptoms. The present study used the EPDS scale and subscale analysis of this group of women because they were regarded as a susceptible population. The COVID‐19 pandemic has become a further example of a catastrophic event that might cause symptoms of postpartum depression. We recognize several limitations to this study. Although EPDS score and anhedonia, anxiety, and depression subscale scores were used to study the psycho‐emotional distress in mothers giving birth during the COVID‐19 pandemic, we did not confirm the diagnosis of postpartum depression in our sample using specific criteria defined in the medical literature. Given its small sample size, this study may have been underpowered to demonstrate a significant effect of the COVID‐19 pandemic on neonatal birth weight. Questions remain regarding the significance of these findings for clinical practice. Furthermore, an intrinsically observational study such as this cannot guarantee that the observed relationships represent causal factors. Finally, the study sample is limited, geographically specific, and not generalizable. However, this should not invalidate the results because the general demographic variables were similar among the groups. Literature on this subject is limited; therefore, the present study makes an important contribution to understanding the impact of a natural infectious calamity on pregnant women. In conclusion, the results of our study indicate that quarantine and hospital containment measures adopted in a COVID‐19 hotspot area in northeastern Italy had a strong psycho‐emotional impact on women giving birth during this period, as indicated by increased EPDS scores and anhedonia and depression subscale scores in the immediate postpartum period. Concerns about risk of exposure to COVID‐19, combined with quarantine measures, can worsen depressive symptoms and adversely affect the thoughts, emotions, and functioning of new mothers.

AUTHOR CONTRIBUTIONS

VZ carried out the study. GS and LS participated in study design. VM and LG participated in study design and coordination. MV helped draft the manuscript. All authors read and approved the final manuscript.

CONFLICTS OF INTEREST

The authors have no conflicts of interest.
  20 in total

1.  Subconstructs of the Edinburgh Postnatal Depression Scale in a multi-ethnic inner-city population in the U.S.

Authors:  Yueh-Hsiu Mathilda Chiu; Perry E Sheffield; Hsiao-Hsien Leon Hsu; Jonathan Goldstein; Paul C Curtin; Rosalind J Wright
Journal:  Arch Womens Ment Health       Date:  2017-08-02       Impact factor: 3.633

Review 2.  Biological and psychosocial predictors of postpartum depression: systematic review and call for integration.

Authors:  Ilona S Yim; Lynlee R Tanner Stapleton; Christine M Guardino; Jennifer Hahn-Holbrook; Christine Dunkel Schetter
Journal:  Annu Rev Clin Psychol       Date:  2015       Impact factor: 18.561

3.  Identification and Management of Peripartum Depression.

Authors:  Robert Langan; Andrew J Goodbred
Journal:  Am Fam Physician       Date:  2016-05-15       Impact factor: 3.292

Review 4.  Effects of prenatal stress on pregnancy and human development: mechanisms and pathways.

Authors:  Mary E Coussons-Read
Journal:  Obstet Med       Date:  2013-05-03

5.  Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale.

Authors:  J L Cox; J M Holden; R Sagovsky
Journal:  Br J Psychiatry       Date:  1987-06       Impact factor: 9.319

6.  Using the Edinburgh Postnatal Depression Scale to screen for anxiety disorders.

Authors:  Stephen Matthey
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

Review 7.  Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.

Authors:  Xiaoxuan Zhao; Yuepeng Jiang; Yang Zhao; Hongyan Xi; Chang Liu; Fan Qu; Xiaoling Feng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-04-23       Impact factor: 3.267

Review 8.  Identifying the women at risk of antenatal anxiety and depression: A systematic review.

Authors:  Alessandra Biaggi; Susan Conroy; Susan Pawlby; Carmine M Pariante
Journal:  J Affect Disord       Date:  2015-11-18       Impact factor: 4.839

Review 9.  Postpartum depression risk factors: A narrative review.

Authors:  Maryam Ghaedrahmati; Ashraf Kazemi; Gholamreza Kheirabadi; Amrollah Ebrahimi; Masood Bahrami
Journal:  J Educ Health Promot       Date:  2017-08-09

Review 10.  Coronavirus disease 2019 (COVID-19) pandemic and pregnancy.

Authors:  Pradip Dashraath; Jing Lin Jeslyn Wong; Mei Xian Karen Lim; Li Min Lim; Sarah Li; Arijit Biswas; Mahesh Choolani; Citra Mattar; Lin Lin Su
Journal:  Am J Obstet Gynecol       Date:  2020-03-23       Impact factor: 8.661

View more
  75 in total

Review 1.  Psychological sequelae within different populations during the COVID-19 pandemic: a rapid review of extant evidence.

Authors:  Xin Jie Jordon Tng; Qian Hui Chew; Kang Sim
Journal:  Singapore Med J       Date:  2020-07-30       Impact factor: 3.331

2.  Maternal Stress and Human Milk Antibodies During the COVID-19 Pandemic.

Authors:  Hannah G Juncker; Eliza J M Ruhé; Aniko Korosi; Johannes B van Goudoever; Marit J van Gils; Britt J van Keulen
Journal:  Front Nutr       Date:  2022-06-30

3.  The risk for nonpsychotic postpartum mood and anxiety disorders during the COVID-19 pandemic.

Authors:  Jelena Stojanov; Miodrag Stankovic; Olivera Zikic; Matija Stankovic; Aleksandar Stojanov
Journal:  Int J Psychiatry Med       Date:  2020-12-15       Impact factor: 1.210

4.  Postpartum during COVID-19 pandemic: Portuguese mothers' mental health, mindful parenting, and mother-infant bonding.

Authors:  Daniela V Fernandes; Maria C Canavarro; Helena Moreira
Journal:  J Clin Psychol       Date:  2021-04-06

Review 5.  The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 infection.

Authors:  Narges Moghimi; Mario Di Napoli; José Biller; James E Siegler; Rahul Shekhar; Louise D McCullough; Michelle S Harkins; Emily Hong; Danielle A Alaouieh; Gelsomina Mansueto; Afshin A Divani
Journal:  Curr Neurol Neurosci Rep       Date:  2021-06-28       Impact factor: 5.081

6.  The level of depression, anxiety, and sleep quality in pregnancy during coronavirus disease 2019 pandemic.

Authors:  Sabri Çolak; Beril Gürlek; Özgür Önal; Bülent Yılmaz; Cicek Hocaoglu
Journal:  J Obstet Gynaecol Res       Date:  2021-06-01       Impact factor: 1.697

7.  Could the Associations of Changes in Living Arrangement with Mental Disorders Be Moderated or Mediated During COVID-19 Pandemic?

Authors:  Ming Guan
Journal:  Psychol Res Behav Manag       Date:  2021-06-16

8.  Perinatal Behavioral Health, the COVID-19 Pandemic, and a Social Determinants of Health Framework.

Authors:  Sharon L Ruyak; Katie T Kivlighan
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2021-06-16

9.  Anxiety and Worries among Pregnant Women during the COVID-19 Pandemic: A Multilevel Analysis.

Authors:  Sara Esteban-Gonzalo; María Caballero-Galilea; Juan Luis González-Pascual; Miguel Álvaro-Navidad; Laura Esteban-Gonzalo
Journal:  Int J Environ Res Public Health       Date:  2021-06-26       Impact factor: 3.390

Review 10.  Mental health effect of COVID-19 pandemic among women who are pregnant and/or lactating: A systematic review and meta-analysis.

Authors:  Dereje Bayissa Demissie; Zebenay Workneh Bitew
Journal:  SAGE Open Med       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.